Anavex Life Sciences Corp. financial data

Symbol
AVXL on Nasdaq
Location
630 5 Th Avenue, 20 Th Floor, New York, NY
Fiscal year end
September 30
Former names
Thrifty Printing Inc. (to 1/25/2007)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 8.55 % +0.24%
Return On Equity -30.6 % +15.5%
Return On Assets -28.2 % +15.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.8M shares +3.47%
Common Stock, Shares, Outstanding 84.8M shares +4.18%
Entity Public Float 667M USD -27.6%
Common Stock, Value, Issued 85K USD +4.43%
Weighted Average Number of Shares Outstanding, Basic 84.5M shares +4.53%
Weighted Average Number of Shares Outstanding, Diluted 84.5M shares +4.53%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 40.3M USD -10.4%
General and Administrative Expense 10.8M USD -18.7%
Operating Income (Loss) -51.2M USD +12.3%
Nonoperating Income (Expense) 9.72M USD +38.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -41.5M USD +19.3%
Net Income (Loss) Attributable to Parent -41.5M USD +19.6%
Earnings Per Share, Basic -0.5 USD/shares 0%
Earnings Per Share, Diluted -0.5 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139M USD -10.4%
Assets 142M USD -10.3%
Accounts Payable, Current 3.5M USD -15.6%
Accrued Liabilities, Current 7.33M USD +22.5%
Liabilities, Current 9.48M USD
Liabilities 11.8M USD +6.32%
Retained Earnings (Accumulated Deficit) -324M USD -14.7%
Stockholders' Equity Attributable to Parent 130M USD -11.6%
Liabilities and Equity 142M USD -10.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.32M USD -26.3%
Net Cash Provided by (Used in) Financing Activities 59K USD -77.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 84.8M shares +4.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 139M USD -10.4%
Deferred Tax Assets, Valuation Allowance 77.2M USD +22.3%
Deferred Tax Assets, Gross 7.2M USD
Deferred Tax Assets, Operating Loss Carryforwards 46.5M USD +0.55%
Current Income Tax Expense (Benefit) 59K USD -79%
Preferred Stock, Shares Authorized 10M shares 0%
Share-based Payment Arrangement, Expense 10.7M USD -44.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%